Prognosis of Arterioportal Fistulas in Liver Tumors
Author Information
Author(s): Anatoly M. Granov, Pavel G. Tarazov, Vladimir K. Ryzhkov
Primary Institution: Central Research Institute of Roentgenology and Radiology, Leningrad, USSR
Hypothesis
What is the prognosis of patients with hepatic tumors and arterioportal fistulas in relation to treatment?
Conclusion
The prognosis for patients with hepatic tumors complicated by arterioportal fistulas is poor, but hepatic resection is the preferred treatment.
Supporting Evidence
- All patients receiving only conservative therapy died of variceal bleeding within two months.
- Three out of four patients who underwent hepatic resection are still alive 13-52 months later.
- Hepatic artery embolization was performed in six patients, but all died within 2-36 months after the procedure.
Takeaway
This study looked at patients with liver tumors and a specific type of blood vessel problem. It found that surgery is the best option for treatment, but many patients still have serious issues.
Methodology
The study analyzed the prognosis of 16 patients with hepatic tumors and arterioportal fistulas based on their treatment.
Limitations
The sample size was small and varied in tumor volume and stage.
Participant Demographics
Patients included those with hepatocellular carcinoma and some with underlying cirrhosis.
Want to read the original?
Access the complete publication on the publisher's website